Patient Association: Myeloma Patients Europe (MPE) (European Union): Difference between revisions
From Beacon
No edit summary |
m (Update categories.) |
||
| Line 1: | Line 1: | ||
<span style="display:none">forpatients</span> | |||
Go back to [[European Union]] page | Go back to [[European Union]] page | ||
| Line 8: | Line 8: | ||
'''Access to information:''' [https://www.mpeurope.org/about-mpe/ Click here to access]. | '''Access to information:''' [https://www.mpeurope.org/about-mpe/ Click here to access]. | ||
<span style="display:none">Blood</span> | |||
<span style="display:none">Bone marrow</span> | |||
<span style="display:none">Lymph nodes</span> | |||
<span style="display:none">Spleen</span> | |||
<span style="display:none">Leukemia</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
Revision as of 13:39, 2 December 2025
Go back to European Union page
Primary purpose: To educate, inform, and support member groups while advocating for the best research, treatment, and care across Europe.
Cancer areas of interest: C81-C96: Cancers of the blood and immune system.
Access to information: Click here to access.